Cycurion, Inc.

Current report

Item 1A. Risk Factors

Current report

We may not realize all of the anticipated benefits of any of our pending acquisitions.

Current report

There is a risk that some or all of the expected benefits of any pending transactions and acquisitions may fail to materialize or may not occur within the time periods anticipated. The realization of such benefits may be affected by a number of factors, many of which are beyond the control of the Company, including, but not limited to, the strength or weakness of the economy and competitive factors in the areas where the Company and other parties in the pending acquisitions or transactions do business, the effects of competition in the markets in which the Company or other parties operate, and the impact of changes in the laws and regulations regulating or affecting domestic or foreign operations. The past financial performance of each of the Company and any potential acquisition may not be indicative of their future financial performance. Realization of the anticipated benefits in pending acquisitions and transactions will depend, in part, on the combined company's ability to successfully integrate the Company's and any acquired businesses. The Company will be required to devote significant management attention and resources to integrating any acquired business's practices. The diversion of management's attention and any delays or difficulties encountered in connection with the pending acquisitions and the coordination of operations could have an adverse effect on the business, financial results, financial condition or the share price of the Company. The coordination process may also result in additional and unforeseen expenses.

Current report

Failure to realize all anticipated benefits of the pending transactions may impact the financial performance of the Company, the price of the Company's common Stock and the ability of the Company to pay dividends on its common stock.

Current report

If we fail to comply with the continued minimum closing bid requirements of the Nasdaq Global Market or other requirements for continued listing, our common stock may be delisted and the price of our common stock and our ability to access the capital markets could be negatively impacted.

Current report

Our common stock is listed for trading on the Nasdaq Global Market. We must satisfy Nasdaq continued listing requirements, including, among other things, a minimum closing bid price requirement of $1.00 per share for 30 consecutive business days. If a company's common stock trades for 30 consecutive business days below the $1.00 minimum closing bid price requirement, Nasdaq will send a deficiency notice to it, advising that it has been afforded a "compliance period" of 180 calendar days to regain compliance with the applicable requirements. Thereafter, if such a company does not regain compliance with the bid price requirement, a second 180-day compliance period may be available.

Current report

On July 22, 2026, the Company announced it requested a hearing before the Panel to appeal the delisting determination the Company received on July 10, 2026, relating to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1). The hearing has been scheduled for August 20, 2026. If the Panel decides to delist our stock the liquidity of our shares of common stock would be adversely impacted, potentially resulting in even lower bid prices for our shares of common stock, and make it more difficult for us to obtain financing through the sale of our shares of common stock.

Previous report

There were no material changes during the three months ended March 31, 2026 to the risk factors previously disclosed in our Annual Report on Form 10-K, filed with the SEC on March 31, 2026.